Sameer Lal, Sr. Vice President at Indegene, shares his extensive knowledge in pharmacovigilance and AI from his 27 years in the industry. He talks about a new study illustrating customer perspectives on pharmacovigilance and the challenges in adopting AI technologies, revealing only 5% of organizations have done so. Lal emphasizes AI's potential to enhance data analysis and customer engagement while encouraging upskilling in the workforce. He also compares generative AI's impact on pharma to major tech revolutions, marking an exciting future for innovation.

In this episode, Sameer Lal, SVP at Indegene, discusses content repurposing, the future of small launches and R&D productivity, the growth of Medical Affairs, using GPT for MLR review, and the role of MAPS in the industry. They also explore challenges in regulatory compliance, content choke in the medical industry, MLR approved content creation, and share industry insights and advice.